Table 3 Comparison of efficacy of doxycycline at different time
DOX group | ATD1 group | ATD2 group | p-value* | |
|---|---|---|---|---|
n = 17 | n = 17 | n = 41 | ||
Age, years | 10 (8.5, 11) | 9 (8.5, 10.5) | 9 (8.5, 10) | 0.545 |
Hospitalization duration(d) | 6 (5, 7) | 7 (7, 9) | 8 (7, 9) | 0.002 |
Fever (n, %) | 15 (88.2%) | 15 (88.2%) | 40 (97.6%) | 0.234 |
Fever duration before treatment(d) | 3 (2, 6.5) | 3 (1.5, 4) | 3 (2, 4) | 0.500 |
Fever duration after treatment(d) | 2 (0, 4) | 3 (2.5, 4) | 4 (3, 5) | 0.011 |
Defervescence within 72 h (n, %) | 10 /15(67%) | 7/15 (47%) | 12 /40(30%) | 0.044 |
Defervescence within 96 h (n, %) | 12/15 (80%) | 13 /15(87%) | 16 /40(40%) | 0.001 |
Chest X-ray improvement (n, %) | 15 (88%) | 13 (76%) | 17 (41%) | 0.001 |
Glucocorticoid(n,%) | 1 (6%) | 1 (6%) | 15 (37%) | 0.007 |